Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filedlitigationCriticalhttps://patents.darts-ip.com/?family=47225757&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MY118194(A)"Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from PCT/US1998/014796external-prioritypatent/WO1999004773A2/en
Application filed by Merck Sharp & DohmefiledCriticalMerck Sharp & Dohme
Publication of MY118194ApublicationCriticalpatent/MY118194A/en
Acyclic And Carbocyclic Compounds In Medicinal Compositions
(AREA)
Abstract
DISCLOSED ARE METHODS FOR INHIBITING BONE RESORPTION IN MAMMALS WHILE MINIMIZING THE OCCURRENCE OF OR POTENTIAL FOR ADVERSE GASTROINTESTINAL EFFECTS. ALSO DISCLOSED ARE PHARMACEUTICAL COMPOSITIONS AND KITS FOR CARRYING OUT THE THERAPEUTIC METHODS DISCLOSE HEREIN. (FIGURE 2)
MYPI98004243A1998-04-151998-09-16Pharmaceutical compositions for use in inhibiting bone resorption
MY118194A
(en)
The use of inhibitors of the renin-angiotensin system for producing pharmaceutical compositions using for the treatment of hypoxia or impaired metabolic function